InCephalo AG

Swiss Biotech Association

Member

InCephalo is a preclinical stage biotech company with a compartment locked (CLocked) technology. InCephalo is positioning itself as a CLocked Fc-Fusion Cytokine and antibody company. The company’s most advanced product at a proprietary IL-12 for local application of brain cancers.

Location

Gewerbestrasse 24, 4123 Allschwil, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2021
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Ariceum International AG

Ariceum International AG is the Swiss affiliate of Ariceum Therapeutics GmbH, a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of hard-to-treat cancers. Ariceum’s lead targeted systemic radiopharmaceutical product, 177Lu-satoreotide tetraxetan.
4051 Basel

Member

InkVivo Technologies AG

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricated novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).
Lugano

Member

GxpManager

GxpManager is a Software editor proposing a SaaS platform with Low Code No Code applications to digitize, manage and process critical data within regulatory requirements in the life sciences sector.
69009 Lyon

Member